The use of topical corticosteroids in a randomized controlled trial was found to be neither beneficial nor harmful in the overall patient population in the study. However, it helped patients who had more serious forms of bacterial corneal ulcers, according to UCSF researchers.
In a paper published this month in the Archives of Ophthalmology, one of the JAMA/Archives journals, researchers found significant vision improvement—one and a half to two lines of improvement on an eye chart—by using steroid therapy on patients with severe ulcers.
"We consider this finding very significant; it's a clinically meaningful difference," said the paper's co-author Nisha Acharya, MD, MS, associate professor and director of the Uveitis Service in the UCSF Department of Ophthalmology. Although secondary to the study's original purpose, Acharya said the results in severe cases were identified early on, so "we didn't start doing all of these analyses after the fact. It was of interest. So I think there is something there."
The use of topical corticosteroids is somewhat controversial within the ophthalmology community, with no specific evidence pointing one way or the other. Concerns include corneal perforation and worsening vision.
"It's important to note that in the worst ulcer group, not only do we not find a safety problem, we actually found that steroids resulted in a benefit in vision," Acharya said. "So I think that is really reassuring because those were the people with whom we were most scared to use steroids."
UCSF researchers collaborated with colleagues at the Aravind Eye Care System, in Madurai, India. They studied 500 participants from the United States and India between September 2006 and February 2010 in the Steroids for Corneal Ulcers Trial (SCUT). Half of the patients received corticosteroid treatment and the other half received placebos.
Complications from contact lens use are the most common culprit in corneal ulcers in the United States, while agriculture-related injuries are the most common in India. Researchers checked participants three months after the start of the trial, testing for visual acuity and corneal perforations. Patients showed no significant improvement in their vision for participants in the corticosteroid treatment group versus those in the control group.
The study also reinforced the use of steroids in treatment of the ulcers because it found that they were not harmful.
"There was no increase in cornea perforations in our patient population," Acharya said. "I'm reassured to know that it's not associated with harm."
Building on their findings, Acharya and her colleagues intend to continue their work, studying patients with even more severe corneal ulcers.
"It makes us feel like we're moving towards an evidence-based paradigm of care for corneal ulcers rather than a trial and error sort of approach," Acharya said. "We have a good collaboration and now that we've had some success with this, we hope to be able to continue with it to answer other questions related to this field."
The lead author of the paper is Muthiah Srinivasan, MD, of Aravind Eye Hospital; co-authors are Jeena Mascarenhas, MD, Revathi Rajaraman, MD, Meenakshi Ravindran, MD, Prajna Lalitha, MD, of Aravind Eye Hospital; David Glidden, PhD, of UCSF Department of Epidemiology and Biostatistics; Thomas Lietman, MD, Kathryn Ray, MA, Kevin Hong, BA, Catherine Oldenburg, MPH, and Salena Lee, OD of The Francis I. Proctor Foundation for Research in Ophthalmology at UCSF; Michael Zegans, MD, of Dartmouth Medical School; and Stephen McLeod, MD, of UCSF Department of Ophthalmology.
The study was supported by funds from the National Institutes of Health (NIH).
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
Follow UCSF on Twitter @ucsf /@ucsfscience
Leland Kim | EurekAlert!
Detecting mental and physical stress via smartphone
22.11.2019 | Politecnico di milano
Virtual "moonwalk" for science reveals distortions in spatial memory
18.11.2019 | Max-Planck-Institut für Kognitions- und Neurowissenschaften
Conventional light microscopes cannot distinguish structures when they are separated by a distance smaller than, roughly, the wavelength of light. Superresolution microscopy, developed since the 1980s, lifts this limitation, using fluorescent moieties. Scientists at the Max Planck Institute for Polymer Research have now discovered that graphene nano-molecules can be used to improve this microscopy technique. These graphene nano-molecules offer a number of substantial advantages over the materials previously used, making superresolution microscopy even more versatile.
Microscopy is an important investigation method, in physics, biology, medicine, and many other sciences. However, it has one disadvantage: its resolution is...
Nanooptical traps are a promising building block for quantum technologies. Austrian and German scientists have now removed an important obstacle to their practical use. They were able to show that a special form of mechanical vibration heats trapped particles in a very short time and knocks them out of the trap.
By controlling individual atoms, quantum properties can be investigated and made usable for technological applications. For about ten years, physicists have...
An international team of scientists, including three researchers from New Jersey Institute of Technology (NJIT), has shed new light on one of the central mysteries of solar physics: how energy from the Sun is transferred to the star's upper atmosphere, heating it to 1 million degrees Fahrenheit and higher in some regions, temperatures that are vastly hotter than the Sun's surface.
With new images from NJIT's Big Bear Solar Observatory (BBSO), the researchers have revealed in groundbreaking, granular detail what appears to be a likely...
The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM in Dresden has succeeded in using Selective Electron Beam Melting (SEBM) to...
15.11.2019 | Event News
15.11.2019 | Event News
05.11.2019 | Event News
22.11.2019 | Life Sciences
22.11.2019 | Health and Medicine
22.11.2019 | Studies and Analyses